GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cannlabs CANL · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

$4.4m

FY2014FY2022

Net income

$869,171

FY2014FY2022

Free cash flow

$772,608

FY2014FY2022

Shareholders' equity

$2.4m

FY2014FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Revenue$4.4m$3.2m$2.8m$2.5m$1.4m$1.4m$1.4m$1.4m
Research and development———————$72
Operating income$872,236$714,300$522,100$804,280−$3.2m−$3.2m−$3.2m−$3.2m
Net income$869,171$712,797$520,571$803,582−$1.6m−$1.6m−$1.6m−$1.6m
Diluted earnings per share0.000.000.000.00-0.00-0.00-0.00-0.03

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Total assets$3.2m$3.0m$2.7m$2.2m$1.3m$1.3m$1.3m$1.3m
Cash and short-term investments$651,026$538,418$498,623$353,290$11,340$11,340$11,340$11,340
Total liabilities$846,116$788,957$782,659$325,417$2.9m$2.9m$2.9m$2.9m
Debt————$1.9m$1.9m$1.9m$1.9m
Shareholders' equity$2.4m$2.2m$1.9m$1.9m$790$790$790$790
Shares outstanding813m813m813m813m813m813m813m60m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Cash from operations$772,608$533,389$570,733$550,619−$1.3m−$1.3m−$1.3m−$1.3m
Capital spending——−$3—−$359,771−$359,771−$359,771−$359,771
Free cash flow$772,608$533,389$570,730$550,619−$1.6m−$1.6m−$1.6m−$1.6m

Latest quarters

By quarter end

Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021
Revenue$1.2m$1.1m$1.1m$1.0m$565,732$1.0m$814,511$785,141
Operating income$365,060$103,390$112,180$291,610$43,250$290,610$183,190$197,260
Net income$364,027$102,601$111,432$291,111$42,787$290,499$182,758$196,753
Diluted earnings per share0.000.000.000.000.000.000.000.00
Total assets$3.2m$3.0m$3.0m$2.9m$3.0m$2.9m$2.9m$2.8m
Cash and short-term investments$651,026$405,165$327,495$265,189$538,418$525,283$549,210$605,419
Shareholders' equity$2.4m$2.2m$2.3m$2.1m$2.2m$2.2m$2.1m$2.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.7%26.3%75.2%
Operating income2.7%——
Net income2.6%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin21.0%22.7%-22.2%-54.5%
Net margin20.9%22.6%-1.7%-19.9%

Valuation history

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings0.20.50.60.1-0.0-0.0-0.0
Price to sales0.10.10.10.00.00.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%-64%24%-38%-10%342%121%48%-37%2701%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 7-for-1 split · 12 Jun 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.